Related by context. All words. (Click for frequent words.) 81 nilotinib 75 imatinib 74 chlorambucil 73 temsirolimus 73 Dasatinib 72 vandetanib 72 tocilizumab 72 bortezomib 72 sorafenib Nexavar 72 SPRYCEL ® 72 imatinib Gleevec 71 cetuximab 71 FOLFIRI 71 gefitinib 71 Fludara 71 anti TNF 71 bendamustine 71 mycophenolate mofetil 71 docetaxel chemotherapy 71 Taxotere ® 70 azacitidine 70 pertuzumab 70 imatinib resistant 70 FOLFOX 70 gefitinib Iressa 70 dasatinib Sprycel 70 tyrosine kinase inhibitors 70 topotecan 70 erlotinib 70 bevacizumab Avastin 70 sunitinib 69 decitabine 69 rituximab 69 bevacizumab 69 erlotinib Tarceva 69 bevacizumab Avastin ® 69 cetuximab Erbitux 69 Torisel 69 vorinostat 69 Velcade bortezomib 69 EGFR TKI 69 adalimumab Humira 69 HER2 positive metastatic breast 69 SPRYCEL 69 Targretin 69 dasatinib Sprycel ® 69 TNF inhibitors 69 docetaxel 69 mRCC 69 cabazitaxel 68 T#I [002] 68 imatinib mesylate Gleevec 68 raltegravir 68 FOLFOX4 68 bosutinib 68 Sprycel 68 DMARDs 68 complete cytogenetic 68 mapatumumab 68 chronic myeloid leukemia CML 68 lapatinib Tykerb 68 dacarbazine 68 pomalidomide 68 EGFR inhibitors 68 ritonavir boosted 68 fludarabine 68 interferon therapy 68 abatacept 68 galiximab 68 peginterferon 68 temozolomide 68 Gleevec imatinib 68 5-FU/LV 68 DOXIL 68 complete cytogenetic response 68 etanercept 68 monotherapy 68 ixabepilone 68 carboplatin paclitaxel 68 Herceptin trastuzumab 68 thalidomide Thalomid 68 visilizumab 68 Gefitinib 68 CCyR 67 cetuximab Erbitux ® 67 imatinib Gleevec ® 67 adalimumab 67 chronic lymphocytic leukemia CLL 67 non metastatic osteosarcoma 67 infliximab 67 Bortezomib 67 trastuzumab 67 Sprycel dasatinib 67 APTIVUS r 67 pazopanib 67 canakinumab 67 LY# [003] 67 sorafenib 67 gemcitabine 67 posaconazole 67 INTELENCE 67 disease modifying antirheumatic 67 Erlotinib 67 NRTIs 67 infusional 5-FU/LV 67 enzastaurin 67 Irinotecan 67 Pemetrexed 67 panitumumab 67 XELOX 67 fluorouracil 67 clodronate 67 mitoxantrone 67 paclitaxel Taxol 67 Bevacizumab 67 azathioprine 67 Fludarabine 67 Gleevec resistant 67 Imatinib 67 leukemia CLL 67 alefacept 67 Doxil ® 67 adefovir 67 aflibercept 67 lamivudine 67 cetuximab Erbitux R 67 glatiramer acetate 66 Aflibercept 66 Jevtana 66 entecavir 66 erlotinib Tarceva ® 66 leukemia AML 66 elotuzumab 66 Tarceva erlotinib 66 metastatic renal cell carcinoma 66 biologic therapy 66 zoledronic acid 66 surrogate endpoint 66 Mylotarg 66 interferon alfa 66 fulvestrant 66 MabCampath 66 CLL SLL 66 ZOLINZA 66 BARACLUDE ® 66 CANCIDAS 66 chemotherapy regimens 66 febuxostat 66 MGd 66 cediranib 66 DMARD 66 etravirine 66 DMARDS 66 metastatic malignant 66 AMN# [001] 66 Noxafil 66 virologic failure 66 leukotriene receptor antagonist 66 oxaliplatin 66 vinorelbine 66 NNRTIs 66 imatinib therapy 66 pegylated liposomal doxorubicin 66 natalizumab 66 talabostat 66 docetaxel Taxotere 66 AZT zidovudine Retrovir 66 tipranavir 66 leukemia ALL 66 abiraterone acetate 66 Tarceva TM 66 bicalutamide 66 trastuzumab Herceptin 66 ACTEMRA TM 66 standard chemotherapy regimen 66 K ras mutations 66 PREZISTA r 66 AVASTIN 66 Amrubicin 66 fingolimod 66 ribavirin RBV 66 TKIs 66 CIMZIA TM 66 relapsed ovarian cancer 66 renal toxicity 66 Vectibix 66 fluvastatin 66 daunorubicin 66 Zolinza 66 tyrosine kinase inhibitor 66 bortezomib Velcade 66 Ceflatonin 66 heavily pretreated 66 NNRTI 65 tigecycline 65 protease inhibitor 65 recurrent glioblastoma multiforme 65 ganetespib 65 estramustine 65 olaparib 65 boosted protease inhibitor 65 iniparib 65 nab paclitaxel 65 TORISEL 65 Revlimid lenalidomide 65 uric acid lowering 65 azacytidine 65 panitumumab Vectibix 65 letrozole 65 pegylated interferons 65 pemetrexed 65 vicriviroc 65 comparator arm 65 FTY# 65 TNF inhibitor 65 SUTENT 65 sustained virologic response 65 peginterferon alfa 2a 65 anakinra 65 T#I mutation 65 eosinophilic asthma 65 docetaxel Taxotere R 65 oblimersen 65 lapatinib 65 DFMO 65 dexamethasone Decadron 65 hypercalcemia 65 darunavir 65 infliximab Remicade 65 idraparinux 65 abatacept Orencia 65 pegfilgrastim 65 mCRC patients 65 Peg IFN 65 Trastuzumab 65 interferon 65 VIDAZA 65 ponatinib 65 Combination therapy 65 Vidaza azacitidine 65 idarubicin 65 ELOXATIN 65 gemcitabine carboplatin 65 plus dexamethasone 65 viral kinetics 65 BAY #-# 65 anti leukemic 65 FOLFIRINOX 65 5 FU 65 Tasigna nilotinib 65 IMGN# 65 nilotinib Tasigna 65 sapacitabine 65 goserelin 65 tipifarnib 65 Reverset 65 Traficet EN 65 Vandetanib 65 clozapine 65 omalizumab 65 xanthine oxidase inhibitor 65 PegIntron 65 TYKERB 65 Alemtuzumab 65 receptor tyrosine kinase inhibitor 65 cytogenetic responses 65 nucleoside analogues 65 Rituxan rituximab 65 Marqibo 65 pegylated interferon alpha 65 Xanafide 64 irinotecan 64 alvespimycin 64 Cloretazine 64 cytogenetic response 64 ASA# 64 flutamide 64 gemcitabine chemotherapy 64 low dose dexamethasone 64 follicular NHL 64 trastuzumab Herceptin ® 64 lenalidomide Revlimid R 64 paricalcitol 64 ISENTRESS 64 anastrozole 64 gastrointestinal stromal tumors 64 Pegasys ® 64 PROMACTA 64 Gemzar ® 64 CIMZIA ™ 64 ULORIC 64 BRIM2 64 FOLPI 64 splenectomized patients 64 Sorafenib 64 follicular lymphoma 64 imatinib mesylate 64 relapsed MM 64 angiotensin converting enzyme inhibitors 64 docetaxel Taxotere ® 64 Fludara ® 64 adriamycin 64 irbesartan 64 sunitinib malate 64 PegIFN RBV 64 Velcade 64 hydroxychloroquine 64 eplerenone 64 Xcytrin 64 bosentan 64 trabectedin 64 ABC/3TC 64 leucovorin 64 BMS # 64 TNF antagonist 64 5 Fluorouracil 64 APTIVUS 64 tenofovir emtricitabine 64 EGFR mutations 64 motesanib 64 CoFactor 64 sunitinib Sutent 64 MAGE A3 ASCI 64 protease inhibitor PI 64 CHOP chemotherapy 64 nucleoside analogue 64 hypomethylating agents 64 OPAXIO 64 adecatumumab 64 T DM1 64 NOXAFIL 64 zalutumumab 64 neoadjuvant treatment 64 Teriflunomide 64 Campath alemtuzumab 64 metastatic colorectal cancer 64 Gleevec imatinib mesylate 64 lumiliximab 64 Navelbine ® 64 peginterferon alfa 2b 64 Temsirolimus 64 YERVOY 64 ACTEMRA 64 Clolar 64 Doxil 64 VAPRISOL 64 indolent NHL 64 Aliskiren 64 baminercept 64 EGFR mutation 64 castration resistant prostate cancer 64 amrubicin 64 Myelodysplastic Syndrome MDS 64 mTOR inhibitor 64 axitinib 64 tumor lysis syndrome 64 OncoVEX GM CSF 64 refractory gout 64 TREANDA 64 interferon ribavirin 64 taxanes 64 Lenalidomide 64 risperidone Risperdal 64 INCB# [003] 64 riociguat 64 differentiated thyroid 64 ACZ# 64 Telintra 64 GRASPA ® 64 oxaliplatin Eloxatin 64 tipranavir ritonavir 64 EGFR tyrosine kinase inhibitor 64 citalopram 64 HGS ETR1 64 calcitriol 64 Flu Cy 64 HRPC 64 metastatic kidney 64 vemurafenib 64 Actemra 64 febrile neutropenia 64 CBLC# 64 forodesine 64 leflunomide 64 active comparator 64 evaluable patients 64 EGFR TKIs 64 HuLuc# 64 eltrombopag 64 Pertuzumab 64 Clofarabine 64 inhibitor RG# 64 TELCYTA 64 doripenem 64 Eltrombopag 64 ORENCIA ® 64 recurrent GBM 64 AP# [003] 63 efalizumab 63 PEGINTRON 63 systemic ALCL 63 mTOR inhibitors 63 Ozarelix 63 ceftriaxone 63 Tasigna 63 tarenflurbil 63 fluoropyrimidine 63 MCyR 63 INC# 63 evaluating tivozanib 63 Femara letrozole 63 gastrointestinal stromal tumors GIST 63 LEXIVA r 63 anti TNFs 63 sipuleucel T 63 BRAF inhibitor 63 NRTI 63 intravenous bisphosphonates 63 Nilotinib 63 virological failure 63 methotrexate 63 abiraterone 63 taxane 63 patients evaluable 63 teriflunomide 63 BRAF mutations 63 imatinib resistance 63 Hycamtin ® 63 Degarelix 63 HBeAg positive patients 63 Abatacept 63 Folfox 63 chemoradiotherapy 63 Enzastaurin 63 ipilimumab 63 cell lymphoma CTCL 63 calcineurin inhibitors 63 EGFr 63 neratinib 63 Roche Pegasys 63 Taxotere 63 glufosfamide 63 GVAX 63 Ph + ALL 63 alkylating agent 63 refractory CLL 63 oral prodrug 63 NSCLC 63 carboplatin 63 adjuvant chemotherapy 63 pegylated interferon 63 response CCyR 63 tenofovir Viread 63 virus HCV protease inhibitor 63 KRAS status 63 AEGR 63 etanercept Enbrel 63 standard chemotherapy regimens 63 BCR ABL 63 mg kg dose 63 Monotherapy 63 INCB# [001] 63 Novartis Gleevec 63 Panitumumab 63 Zarnestra 63 Taxol paclitaxel 63 sitagliptin 63 MGCD# [001] 63 B CLL 63 Etanercept 63 Hycamtin 63 nelfinavir 63 rFVIIa 63 Gleevec 63 metastatic hormone refractory 63 peginterferon alfa 63 remission induction 63 VFEND 63 follicular lymphoma FL 63 REMICADE ® 63 allopurinol 63 Omacetaxine 63 ribavirin therapy 63 heavily pretreated patients 63 neoadjuvant chemotherapy 63 Hematologic 63 Exemestane 63 pegylated interferon alfa 2b 63 TNF antagonists 63 Elotuzumab 63 aromatase inhibitor 63 HGS# 63 BEACOPP 63 Seliciclib 63 metastatic RCC 63 corticosteroid therapy 63 metastatic castration resistant 63 EGFR inhibitor 63 GW# [003] 63 Response Evaluation Criteria 63 hypereosinophilic syndrome 63 interferon alfa 2b 63 TNFα 63 IRESSA 63 chemoradiation 63 nitazoxanide 63 afatinib 63 Dapagliflozin 63 PXD# 63 Adalimumab 63 reslizumab 63 plus gemcitabine 63 pimozide 63 Pharmacokinetics PK 63 anti androgen 63 ara C 63 antiviral therapy 63 5FU 63 ATACAND 63 Metastatic Colorectal Cancer 63 refractory chronic myeloid 63 VEGF inhibitors 63 Copegus ribavirin 63 efavirenz EFV 63 HCV RESPOND 2 63 tyrosine kinase inhibitors TKIs 63 Riluzole 63 Diovan HCT 63 superficial bladder cancer 63 antibody MAb 63 cilengitide 63 Ixempra 63 Lapatinib 63 Treanda 63 abacavir lamivudine 63 achieved CCyR 63 octreotide LAR 63 mg dose 63 AZILECT 63 levosimendan 63 gemcitabine Gemzar 63 neurologic progression 63 paclitaxel Taxol ® 63 QTc prolongation 63 Telbivudine 63 lenalidomide 63 ZACTIMA 63 Epratuzumab 63 Pegintron 63 biologic DMARD 63 cilostazol 63 refractory AML 63 protease inhibitors 63 SCCHN 63 registrational trial 63 tamoxifen 63 tumor shrinkage 63 tanespimycin 63 rHuPH# 63 crizotinib PF # 63 virologic response 63 acute myelogenous leukemia AML 63 montelukast 63 ketoconazole 63 TMC# [001] 63 refractory chronic lymphocytic 63 GSK# [001] 63 peginterferon alpha 2a 63 Pegylated Interferon 63 platinum refractory 63 huC# DM4 63 Interferon alpha 63 HuMax EGFr 63 carvedilol 62 piperacillin tazobactam 62 Revlimid 62 AZILECT R 62 cisplatin chemotherapy 62 huN# DM1 62 telbivudine 62 adjuvant therapy 62 efavirenz Sustiva 62 ibandronate 62 REYATAZ R 62 CCR5 antagonist 62 placebo dexamethasone 62 dutasteride 62 oral rivaroxaban 62 myelofibrosis polycythemia vera 62 cangrelor 62 Mitoxantrone 62 ZD# [001] 62 cardiac toxicity 62 trans retinoic acid 62 sorafenib tablets 62 nonresponders 62 hematologic toxicity 62 Cetuximab 62 MetMAb 62 Darunavir 62 epithelial tumors 62 Amigal 62 Epidermal Growth Factor Receptor 62 Pazopanib 62 TLK# 62 Epivir 62 teriparatide 62 Amplimexon 62 Cutaneous T 62 anthracycline chemotherapy 62 peg IFN 62 fluconazole 62 dose cohorts 62 desvenlafaxine succinate 62 telaprevir dosed 62 Navelbine 62 Cytoxan 62 capecitabine 62 pyrazinamide 62 KRAS mutations 62 cisplatin 62 eribulin 62 Panzem R NCD 62 oxcarbazepine 62 G CSF 62 interferon alpha 62 neoadjuvant 62 celgosivir 62 EGFR tyrosine kinase inhibitors 62 chemotherapeutic agents 62 S/GSK# 62 taxane therapy 62 tolvaptan 62 arsenic trioxide 62 lixisenatide 62 sunitinib Sutent ® 62 FluCAM 62 pegylated interferon alfa 62 relapsed refractory 62 enfuvirtide 62 Pralatrexate 62 Tyrima 62 RoACTEMRA 62 Rituxan 62 TELINTRA 62 amoxicillin clavulanate 62 alkylating agents 62 Paraplatin ® 62 peginterferon alfa 2a Pegasys 62 3TC lamivudine Epivir 62 aflibercept VEGF Trap 62 phase IIb clinical 62 metastatic CRC 62 AEG# 62 colorectal liver metastases 62 antihypertensive therapy 62 5 fluorouracil 62 Fulvestrant 62 cytotoxic chemotherapy 62 Lamivudine 62 melphalan prednisone 62 cytarabine 62 Lamotrigine 62 TDF FTC 62 PRT# 62 follicular lymphomas 62 Aptivus ® 62 ruboxistaurin 62 nicardipine 62 lenalidomide dexamethasone 62 YONDELIS 62 aprepitant 62 Rituximab 62 itraconazole 62 olmesartan 62 XmAb# 62 Tavocept 62 pan HDAC inhibitor 62 paroxetine Paxil 62 HBeAg negative patients 62 FOLFOX6 62 beta 1a 62 valopicitabine 62 gadobutrol 62 alfa 2a 62 sorafenib Nexavar ® 62 rituximab Rituxan 62 Gemcitabine 62 complete remissions 62 endometrial hyperplasia 62 DU #b 62 DAPT 62 velafermin 62 zolmitriptan 62 Omnitarg 62 CYC# 62 Tarceva 62 Cremophor 62 ELND# 62 myelodysplastic syndrome MDS 62 mepolizumab 62 HBeAg positive 62 plus prednisone 62 Xelox 62 exemestane 62 Epivir HBV 62 dose limiting toxicities 62 FASLODEX 62 Chronic Lymphocytic Leukemia CLL 62 Votrient 62 cyclophosphamide Cytoxan 62 Bosutinib 62 anticancer therapies 62 anthracycline taxane 62 GnRH agonists 62 trastuzumab DM1 62 TKI therapy 62 dexpramipexole 62 tobramycin 62 IRX 2 62 proteasome inhibitor 62 Bezielle 62 interferons 62 HBeAg negative 62 obatoclax 62 CDK inhibitor 62 subcutaneously administered 62 Elitek 62 figitumumab 62 etoposide 62 perifosine 62 oral vancomycin 62 low dose cytarabine 62 metastatic malignant melanoma 62 MyVax R 62 bevacizumab Avastin R 62 #mg BID [001] 62 Tamibarotene 62 advanced NSCLC 62 PEG IFN 62 Peginterferon alfa 2b 62 SERMs 62 sitaxsentan 62 ocrelizumab 62 ZYVOX 62 NATRECOR R 62 Azacitidine 62 prior chemotherapy regimens 62 PEGINTRON TM 62 TNF blocker therapy 62 sargramostim 62 XGEVA 62 AGILECT R 62 antipsychotic 62 Avastin bevacizumab 62 aripiprazole Abilify 62 fosamprenavir 62 Dacogen injection 62 prucalopride 62 atypical hemolytic uremic syndrome 62 sertraline Zoloft 62 anidulafungin 62 seliciclib 62 antithrombotic 62 proteasome inhibitors 62 HCV SPRINT 62 divalproex sodium 62 aripiprazole 62 lesinurad 62 ustekinumab 62 metastatic colorectal 62 Platinol ® 62 cinacalcet 62 Vfend 62 refractory NSCLC 62 Virologic 62 Annamycin 62 chemotherapeutic drug 62 eculizumab 62 selegiline 62 PEGylated interferon beta 1a 62 rizatriptan 62 Pivotal Phase III 62 rasagiline 62 CYT# potent vascular disrupting 62 steroid dexamethasone 62 Laquinimod 62 Roche Xeloda 62 indinavir 62 recurrent NSCLC 62 fluticasone 62 apremilast 62 DEB# 62 trimethoprim sulfamethoxazole 61 stavudine 61 Onrigin 61 essential thrombocythemia 61 LAF# 61 haloperidol Haldol 61 plus ribavirin 61 NVA# 61 relapsing MS 61 pentoxifylline 61 Symbyax 61 virologic 61 Gleevec Glivec 61 polymerase inhibitor 61 immunomodulatory therapy 61 invasive aspergillosis 61 pemetrexed Alimta 61 trabedersen 61 antitumor activity 61 stavudine d4T 61 amifostine 61 Arixtra 61 bleomycin 61 proteasome inhibitor bortezomib 61 Romiplostim 61 anthracyclines taxanes 61 non squamous NSCLC 61 Lacosamide 61 COPD exacerbations 61 cancer mCRC 61 Imprime PGG 61 valsartan 61 nilotinib Tasigna ® 61 DAVANAT 61 certolizumab 61 Neulasta ® 61 nephrotoxicity 61 Peginterferon 61 5 FU leucovorin 61 Aromasin 61 Roche Actemra 61 ELACYT 61 intermittent dosing 61 insulin detemir 61 Capecitabine 61 phase Ib 61 odanacatib 61 voriconazole 61 adverse cytogenetics 61 #I TM# 61 regorafenib 61 eribulin mesylate 61 galantamine 61 pegylated liposomal doxorubicin PLD 61 myeloproliferative disorders 61 OHR/AVR# 61 Chronic Myeloid Leukemia 61 Neuvenge 61 romiplostim 61 OXi# 61 trastuzumab Herceptin R 61 fondaparinux 61 Afatinib 61 lupus nephritis 61 Valsartan 61 PEGylated Fab fragment 61 dose cytarabine 61 tinidazole 61 gemifloxacin 61 anthracycline containing 61 relapsed multiple myeloma 61 virological response 61 palonosetron 61 Vidofludimus 61 metastatic GIST 61 chronic myelogenous leukemia CML 61 plasma uric acid 61 KRAS mutation 61 irinotecan chemotherapy 61 olanzapine Zyprexa 61 Carfilzomib 61 imipenem 61 Hodgkin lymphoma NHL 61 EXJADE 61 placebo controlled clinical 61 atazanavir 61 ziprasidone Geodon 61 COPAXONE R 61 HuMax CD# 61 dose regimens 61 Bisphosphonate 61 oral JAK1 61 fibrinolytic 61 Crestor rosuvastatin 61 dose cohort 61 HER2 overexpression 61 weekly subcutaneous injections 61 ximelagatran 61 disease progression 61 dosing cohorts 61 Neoadjuvant 61 Kantarjian 61 IMC A# 61 VIRAMUNE 61 therapeutic regimens 61 ALT flares 61 angiogenesis inhibitor 61 Zileuton 61 imetelstat 61 gemcitabine Gemzar ® 61 Phase 2a trial 61 investigational humanized monoclonal antibody 61 ofatumumab 61 elvitegravir 61 Bosentan 61 rilpivirine 61 FOSRENOL ® 61 nucleoside analogs 61 stage IIIB 61 dacetuzumab 61 clopidogrel Plavix 61 linezolid 61 β blockers 61 samalizumab 61 metastatic renal cell 61 rNAPc2 61 sulindac 61 Hormone Refractory Prostate Cancer 61 carfilzomib 61 Remicade infliximab 61 oral Xeloda 61 pharmacokinetic interactions 61 interferon gamma 1b 61 Nexavar sorafenib 61 cytotoxic therapy 61 relapsed SCLC 61 fluticasone salmeterol 61 CR nPR 61 assessing T DM1 61 limiting toxicity 61 Ophena TM 61 immunomodulator 61 histone deacetylases 61 Tesmilifene 61 sulfasalazine 61 ONTAK 61 epirubicin 61 ISTODAX 61 gastrointestinal stromal tumor GIST 61 Elvitegravir 61 Everolimus 61 octreotide 61 nucleoside reverse transcriptase inhibitor 61 metaglidasen 61 Vaprisol 61 Pixantrone 61 dalteparin 61 mcg kg 61 TYZEKA 61 Erbitux cetuximab 61 tiotropium 61 Paxil paroxetine 61 achieve sustained virologic 61 Taxol ® 61 darunavir ritonavir 61 Interferon alfa 61 recurrent genital herpes 61 Meets Primary Endpoint 61 pancreatic adenocarcinoma 61 SCH # 61 interferon IFN 61 Platinol 61 Celecoxib 61 tenofovir DF 61 indacaterol 61 mg/m2 dose 61 leukotriene receptor antagonists 61 letrozole Femara 61 endothelin receptor antagonists 61 Gliadel Wafer 61 dose dexamethasone 61 zafirlukast 61 alvimopan 61 mg QD 61 hormone refractory prostate cancer 61 IFN beta 61 Kinoid 61 PSMA ADC 61 brain metastases 61 Camptosar ® 61 NEUPOGEN 61 brivaracetam 61 palifermin 61 chemotherapy docetaxel 61 preoperative chemotherapy 61 lamotrigine 61 lopinavir r 61 mecamylamine 61 mg BID 61 Tocilizumab 61 FLT3 61 tyrosine kinase inhibitor TKI 61 beta2 agonist 61 lopinavir 61 relapsed CLL 61 ImClone Erbitux